mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme
Status:
Completed
Trial end date:
2020-02-25
Target enrollment:
Participant gender:
Summary
The standard or usual treatment for this disease is standard chemotherapy alone. AZD2014 is a
new type of drug for glioblastoma multiforme. In the laboratory it has been shown to slow the
growth of glioblastoma multiforme. In some animal studies AZD2014 seemed to work better when
given with a drug called temozolomide.